Home LiteratureArticle Details
PMID: 8419635 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Distinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain.

Journal of virology ·Vol. 67 ·No. 2 ·1993-02-00 ·Pages 1006-14

Barnett SW, Quiroga M, Werner A, Dina D, Levy JA

Abstract

A full-length infectious molecular clone was derived from the noncytopathic human immunodeficiency virus type 2 UC1 strain (HIV-2UC1) that was originally recoverd from an individual from the Ivory Coast. Like the parental isolate, the molecularly cloned virus (HIV-2UC1mc or UC1 mc) demonstrates a reduced ability to induce syncytium formation, to kill cells, and to down-modulate the cell surface CD4 receptor in infected cells. Phylogenetic analysis of the DNA sequence of UC1mc revealed that it is the first full-length infectious molecular clone in the second HIV-2 subgroup previously identified by partial sequence analysis of the HIV-2D205 and HIV-2GH-2 strains. These highly divergent HIV-2 strains appear to be genetically equidistant from other HIV-2 and simian immunodeficiency virus SIVmac/sm strains. UC1mc is unlike any other HIV-2 or SIVmac/sm strain in that it lacks a cysteine residue at the proposed signal peptide cleavage site in Env. However, site-directed mutagenesis experiments indicate that this missing cysteine is not alone important in the noncytopathic phenotype of UC1mc. Like other HIV-2 and SIV strains, the UC1mc Env transmembrane protein (gp43) is mutated to a truncated form (gp34) after passage in certain T-cell lines. The UC1 molecular clone should be helpful in determining the genetic sequences associated with HIV-2 cytopathicity.

Related Genes
env
MeSH Terms
Amino Acid Sequence Base Sequence CD4 Antigens/biosynthesis Cell Fusion Cloning, Molecular Down-Regulation Genetic Variation HIV Long Terminal Repeat/genetics HIV Seropositivity/immunology HIV-2/classification,genetics,immunology,pathogenicity Humans Molecular Sequence Data Neutralization Tests Phylogeny Sequence Homology, Amino Acid Viral Envelope Proteins/classification,genetics,immunology Virulence
Chemicals
CD4 Antigens Viral Envelope Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Barnett S W
Cancer Research Institute, School of Medicine, University of California, San Francisco 94143-0128.
Quiroga M
Werner A
Dina D
Levy J A
References (58)
58 references, click to expand
  1. Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein.
    J Virol. 1991 Jan;65(1):281-91 PMID: 1702159
  2. Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion.
    J Virol. 1990 Dec;64(12):6314-8 PMID: 2243396
  3. Establishment of a phylogenetic survey system for AIDS-related lentiviruses and demonstration of a new HIV-2 subgroup.
    AIDS. 1990 Dec;4(12):1257-61 PMID: 1965125
  4. Role of the fusogenic peptide sequence in syncytium induction and infectivity of human immunodeficiency virus type 2.
    J Virol. 1992 Jul;66(7):4532-5 PMID: 1602558
  5. Pattern-induced multi-sequence alignment (PIMA) algorithm employing secondary structure-dependent gap penalties for use in comparative protein modelling.
    Protein Eng. 1992 Jan;5(1):35-41 PMID: 1631044
  6. Human infection by genetically diverse SIVSM-related HIV-2 in west Africa.
    Nature. 1992 Aug 6;358(6386):495-9 PMID: 1641038
  7. Analysis of a human immunodeficiency virus type 1 isolate carrying a truncated transmembrane glycoprotein.
    Virology. 1992 Aug;189(2):534-46 PMID: 1322587
  8. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.
    Science. 1991 Jul 5;253(5015):71-4 PMID: 1905842
  9. Characterization of human immunodeficiency virus type 1 strains recovered from the bowel of infected individuals.
    Virology. 1991 Jun;182(2):802-9 PMID: 2024498
  10. Analysis of the envelope region of the highly divergent HIV-2ALT isolate extends the known range of variability within the primate immunodeficiency viruses.
    AIDS Res Hum Retroviruses. 1992 Sep;8(9):1619-29 PMID: 1457208
  11. Cytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4.
    J Virol. 1991 Sep;65(9):5096-101 PMID: 1870213
  12. Hypothetical assignment of intrachain disulfide bonds for HIV-2 and SIV envelope glycoproteins.
    AIDS Res Hum Retroviruses. 1991 Jun;7(6):495-9 PMID: 1931228
  13. Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120.
    J Virol. 1991 Dec;65(12):6931-41 PMID: 1658383
  14. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity.
    J Virol. 1992 Feb;66(2):757-65 PMID: 1731110
  15. Structure and function in recombinant HIV-1 gp120 and speculation about the disulfide bonding in the gp120 homologs of HIV-2 and SIV.
    Adv Exp Med Biol. 1991;303:1-14 PMID: 1805558
  16. Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types.
    J Virol. 1992 Jun;66(6):3971-5 PMID: 1583738
  17. DNA sequencing with chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PMID: 271968
  18. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.
    Science. 1984 Aug 24;225(4664):840-2 PMID: 6206563
  19. Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).
    J Immunol Methods. 1985 Jan 21;76(1):171-83 PMID: 2981931
  20. Long-term cultivation of T-cell subsets from patients with acquired immune deficiency syndrome.
    Clin Immunol Immunopathol. 1985 Jun;35(3):328-36 PMID: 3157520
  21. High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states.
    Proc Natl Acad Sci U S A. 1985 Aug;82(16):5535-9 PMID: 2991932
  22. Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions.
    Virology. 1985 Dec;147(2):326-35 PMID: 2416116
  23. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
    Nature. 1986 Jul 31-Aug 6;322(6078):470-4 PMID: 3016552
  24. Epitopes of the CD4 antigen and HIV infection.
    Science. 1986 Nov 28;234(4780):1120-3 PMID: 2430333
  25. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV.
    Science. 1986 Nov 28;234(4780):1123-7 PMID: 3095925
  26. Molecular cloning and polymorphism of the human immune deficiency virus type 2.
    Nature. 1986 Dec 18-31;324(6098):691-5 PMID: 3025743
  27. Genome organization and transactivation of the human immunodeficiency virus type 2.
    Nature. 1987 Apr 16-22;326(6114):662-9 PMID: 3031510
  28. The genome organization of STLV-3 is similar to that of the AIDS virus except for a truncated transmembrane protein.
    Cell. 1987 May 8;49(3):307-19 PMID: 3646094
  29. Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses.
    Nature. 1987 Aug 6-12;328(6130):543-7 PMID: 3649576
  30. Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group.
    Nature. 1988 Jun 2;333(6172):457-61 PMID: 3374586
  31. Characterization of a noncytopathic HIV-2 strain with unusual effects on CD4 expression.
    Science. 1988 Jun 10;240(4858):1522-5 PMID: 2836951
  32. West African HIV-2-related human retrovirus with attenuated cytopathicity.
    Science. 1988 Jun 10;240(4858):1525-9 PMID: 3375832
  33. Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1.
    Proc Natl Acad Sci U S A. 1988 Aug;85(16):5941-5 PMID: 3261862
  34. Simultaneous isolation of HIV-1 and HIV-2 from an AIDS patient.
    Lancet. 1988 Dec 17;2(8625):1389-91 PMID: 2904524
  35. Identification of simian immunodeficiency virus SIVMAC env gene products.
    J Virol. 1989 Mar;63(3):1416-9 PMID: 2464704
  36. Human immunodeficiency virus cell entry: new insights into the fusion mechanism.
    J Acquir Immune Defic Syndr. 1988;1(6):579-82 PMID: 2852244
  37. Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells.
    J Clin Microbiol. 1988 Nov;26(11):2371-6 PMID: 3266220
  38. Molecular cloning of two west African human immunodeficiency virus type 2 isolates that replicate well in macrophages: a Gambian isolate, from a patient with neurologic acquired immunodeficiency syndrome, and a highly divergent Ghanian isolate.
    Proc Natl Acad Sci U S A. 1989 Apr;86(7):2383-7 PMID: 2467304
  39. Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone.
    Proc Natl Acad Sci U S A. 1989 Apr;86(7):2433-7 PMID: 2648404
  40. Isolation of human immunodeficiency virus-related simian immunodeficiency viruses from African green monkeys.
    Proc Natl Acad Sci U S A. 1989 Apr;86(8):2892-6 PMID: 2468160
  41. Identification of the fusion peptide of primate immunodeficiency viruses.
    Science. 1989 May 12;244(4905):694-7 PMID: 2541505
  42. The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells.
    Science. 1989 Jun 16;244(4910):1357-60 PMID: 2786647
  43. Single amino-acid changes in HIV envelope affect viral tropism and receptor binding.
    Nature. 1989 Aug 17;340(6234):571-4 PMID: 2475780
  44. The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity.
    J Virol. 1989 Oct;63(10):4395-403 PMID: 2778881
  45. Significance of premature stop codons in env of simian immunodeficiency virus.
    J Virol. 1989 Nov;63(11):4709-14 PMID: 2795718
  46. A highly divergent HIV-2-related isolate.
    Nature. 1989 Dec 21-28;342(6252):948-50 PMID: 2594088
  47. Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate.
    J Virol. 1990 Feb;64(2):890-901 PMID: 2296086
  48. Genomic divergence of HIV-2 from Ghana.
    AIDS Res Hum Retroviruses. 1989 Dec;5(6):593-604 PMID: 2611042
  49. Characteristics of HIV infection and pathogenesis.
    Biochim Biophys Acta. 1989 Dec 27;989(3):237-54 PMID: 2695168
  50. Rapid and sensitive sequence comparison with FASTP and FASTA.
    Methods Enzymol. 1990;183:63-98 PMID: 2156132
  51. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41.
    Proc Natl Acad Sci U S A. 1990 Jun;87(12):4650-4 PMID: 2191297
  52. The env protein of an infectious noncytopathic HIV-2 is deficient in syncytium formation.
    AIDS Res Hum Retroviruses. 1990 Jun;6(6):707-20 PMID: 2364016
  53. Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome.
    J Virol. 1990 Aug;64(8):4016-20 PMID: 2370688
  54. Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation.
    J Virol. 1990 Sep;64(9):4390-8 PMID: 2384920
  55. Biologic heterogeneity of human immunodeficiency virus type 2 (HIV-2) strains.
    Virology. 1990 Oct;178(2):527-34 PMID: 2120848
  56. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain.
    Nature. 1990 Nov 1;348(6296):69-73 PMID: 2172833
  57. The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue.
    J Virol. 1990 Dec;64(12):6148-53 PMID: 2243391
  58. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene.
    Nature. 1991 Jan 10;349(6305):167-9 PMID: 1986308
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1993-02-00
Pages
1006-14
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC237455
Subset
IM
Grants
NIAID NIH HHS · AI24286-05 · United States
Databases
GENBANK
L07625
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com